These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19093333)

  • 21. [Overview of FAB/WHO classification and therapeutic modalities for myelodysplastic syndromes].
    Kanamaru A
    Rinsho Ketsueki; 2004 Apr; 45(4):261-7. PubMed ID: 15168440
    [No Abstract]   [Full Text] [Related]  

  • 22. Treating low-risk myelodysplastic syndromes in the community setting.
    Cripe LD
    Clin Adv Hematol Oncol; 2008 Jun; 6(6):418-20. PubMed ID: 18567986
    [No Abstract]   [Full Text] [Related]  

  • 23. [The strategy for the treatment of myelodysplastic syndromes].
    Hideaki M
    Rinsho Ketsueki; 2002 Mar; 43(3):157-60. PubMed ID: 11979745
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple myeloma: epidemiology and therapeutic options.
    Tuscano JM
    Manag Care; 2008 Jul; 17(7 Suppl 6):9-15. PubMed ID: 19093334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myelodysplastic Syndromes.
    Cazzola M
    N Engl J Med; 2020 Oct; 383(14):1358-1374. PubMed ID: 32997910
    [No Abstract]   [Full Text] [Related]  

  • 26. The hematologist's approach to myelodysplastic syndrome.
    Fukumoto JS
    Hawaii Med J; 2008 Jun; 67(6):164-6. PubMed ID: 18678209
    [No Abstract]   [Full Text] [Related]  

  • 27. Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010.
    Sekeres MA
    J Natl Compr Canc Netw; 2011 Jan; 9(1):57-63. PubMed ID: 21233244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in myelodysplastic syndromes.
    Garcia-Manero G
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S286-92. PubMed ID: 19778854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis, biology, and management of myelodysplastic syndromes in children.
    Haas OA; Gadner H
    Semin Hematol; 1996 Jul; 33(3):225-35. PubMed ID: 8819232
    [No Abstract]   [Full Text] [Related]  

  • 30. Future frontiers in the treatment of myelodysplastic syndromes.
    ONS News; 2004; 19(9 Suppl):19-20. PubMed ID: 15478571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NCCN practice guidelines for the myelodysplastic syndromes. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1998 Nov; 12(11A):53-80. PubMed ID: 10028503
    [No Abstract]   [Full Text] [Related]  

  • 32. The myelodysplastic syndromes.
    Nguyen PL
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):675-91. PubMed ID: 19577164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flowcytometry in myelodysplastic syndromes: towards a new paradigm in diagnosis and prognostication?
    van de Loosdrecht AA; Westers TM; Ossenkoppele GJ
    Leuk Res; 2008 Feb; 32(2):205-7. PubMed ID: 17714781
    [No Abstract]   [Full Text] [Related]  

  • 34. Consensus statement on iron overload in myelodysplastic syndromes.
    Bennett JM;
    Am J Hematol; 2008 Nov; 83(11):858-61. PubMed ID: 18767130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myelodysplastic syndromes: clinically relevant aspects in diagnosis, prognosis and prediction].
    Noesslinger T; Pfeilstoecker M
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2086-90. PubMed ID: 18985562
    [No Abstract]   [Full Text] [Related]  

  • 36. World Health Organization and international prognostic scoring system: the limitations of current classification systems in assessing prognosis and determining appropriate therapy in myelodysplastic syndromes.
    Schiffer CA
    Semin Hematol; 2008 Jan; 45(1):3-7. PubMed ID: 18179963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk-stratified treatment strategy for myelodysplastic syndromes].
    Ichikawa M
    Rinsho Ketsueki; 2012 Oct; 53(10):1509-15. PubMed ID: 23037723
    [No Abstract]   [Full Text] [Related]  

  • 38. Red cell transfusion thresholds in myelodysplastic syndromes: a clinician survey to inform future clinical trials.
    Mo A; McQuilten ZK; Wood EM; Weinkove R
    Intern Med J; 2017 Jun; 47(6):695-698. PubMed ID: 28580745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unraveling the mysteries of MDS: linking science to practice through case studies.
    Oestreicher P
    ONS Connect; 2007; 22(8 Suppl):61-2. PubMed ID: 17824569
    [No Abstract]   [Full Text] [Related]  

  • 40. Incremental gains and a long road ahead in MDS.
    Steensma DP; Tefferi A
    Oncology (Williston Park); 2008 Nov; 22(12):1352, 1358, 1360. PubMed ID: 19320067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.